Dapagliflozin Evaluation on Atrial Fibrillation Patients Followed Cox Maze IV Procedure
Conditions: Atrial Fibrillation Recurrence; Cox Maze IV; Atrial Fibrillation; Patients With or Without Heart Failure and Diabetes Interventions: Drug: Dapagliflozin; Drug: Placebo Sponsor: Kun Hua Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Atrial Fibrillation | Cardiology | Dapagliflozin | Diabetes | Endocrinology | Forxiga | Heart | Heart Failure | Research